Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06380166 · ClinicalTrials.gov registry record
Hepatitis C Lab Testing Comparison Study
A clinical trial, sponsored by HealthPartners Institute.
- Terminated
- Registry status
- 1
- Enrollment target
NCT06380166 is a clinical trial that was terminated before completion, run by HealthPartners Institute. The registered enrollment target is 1 participants.
The verdict
NCT06380166 was terminated before completion, sponsored by HealthPartners Institute.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Hepatitis C (HCV) HCV antibody assays are the standard of care test used to screen for HCV, but confirmation of acute infection is relegated in the current US guidelines to polymerase chain reaction (PCR) which often takes multiple days and may result in a loss to follow up and treatment, especially in high prevalence populations. HCV core antigen is a new, research use only immunoassay intended for use on the Abbott Alinity i system, an FDA-cleared instrument for clinical chemistry and immunoassay testing. The aim of the study is to evaluate the 48-hour stability of HCV core antigen in fresh serum and plasma specimens collected from individuals with a detectable HCV viral load (HCL VL), as per a recent antibody assay test, under multiple specimen storage conditions mirroring those employed in clinical laboratories.
Interventions
- DIAGNOSTIC_TEST Hepatitis C core antigen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-07-24 |
| Est. Completion | 2024-12-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06380166
The ClinicalTrials.gov registry entry for NCT06380166 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hepatitis C core antigen is the first listed.
NCT06380166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06380166 about?
NCT06380166 is a clinical study titled "Hepatitis C Lab Testing Comparison Study". Hepatitis C (HCV) HCV antibody assays are the standard of care test used to screen for HCV, but confirmation of acute infection is relegated in the current US guidelines to polymerase chain reaction (PCR) which often takes multiple days and may result in a loss to follow up and treatment, especially...
What is the current status of trial NCT06380166?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2024-07-24. Estimated completion is 2024-12-06.
What interventions are being tested in trial NCT06380166?
The interventions under investigation include: Hepatitis C core antigen (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06380166?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.